Modeling Sarcopenia to Predict Survival for Patients With Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy

समान संसाधन

• A Model Combining Skeletal Muscle Mass and a Hematological Biomarker to Predict Survival in Patients With Nasopharyngeal Carcinoma Undergoing Concurrent Chemoradiotherapy
  द्वारा: Huang, Han-Ying, और अन्य
  प्रकाशित: (2021)
• Sarcopenia is associated with higher toxicity and poor prognosis of nasopharyngeal carcinoma
  द्वारा: Hua, Xin, और अन्य
  प्रकाशित: (2020)
• Low Skeletal Muscle Mass Impairs Quality of Life in Nasopharyngeal Carcinoma Patients Treated With Concurrent Chemoradiotherapy
  द्वारा: Hua, Xin, और अन्य
  प्रकाशित: (2020)
• Establishment and Validation of Nomogram Based on Combination of Pretreatment C-Reactive Protein/Albumin Ratio–EBV DNA Grade in Nasopharyngeal Carcinoma Patients Who Received Concurrent Chemoradiotherapy
  द्वारा: Huang, Zhang-Zan, और अन्य
  प्रकाशित: (2021)
• The Cumulative Cisplatin Dose Affects the Long-Term Survival Outcomes of Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy
  द्वारा: Peng, Hao, और अन्य
  प्रकाशित: (2016)